An analysis of the NIMH CATIE trial shows that negative symptoms have a greater impact on functioning, quality of life, and outcomes than positive symptoms in schizophrenia. This analysis was motivated by a recognition of functioning, rather than the management of positive symptoms, as a target of treatment. The analysis was published in Schizophrenia Research.
Abstract → Discuss →
